Global E-Prescribing Market to Grow at a CAGR of 23.5% from 2013 to 2019 : Persistence Market Research

The global E-Prescribing market is categorized based on various product type, components, delivery mode, usage mode and end users. The product type segmentation is further sub-segmented into integrated and stand-alone system.

Logo

New York, NY -- (SBWire) -- 04/21/2015 --According to a new market report published by Persistence Market Research "Global Market Study on E-Prescribing: North America to Witness Highest Growth by 2019," the global E-Prescribing market was valued at USD 250.2 million in 2013 and is expected to grow at a CAGR of 23.5% from 2013 to 2019, to reach an estimated value of USD 887.8 million in 2019.

Browse the full Global Market Study on E-Prescribing: North America to Witness Highest Growth by 2019 report at http://www.persistencemarketresearch.com/market-research/e-prescribing-market.asp

Electronic prescribing or E-Prescribing (e-Rx) is electronic transmission of prescriptions from physician to pharmacists using computer and other mobile devices, such as cell phone and tablets. E-Prescribing systems are used in preparation of complete medication list, data security checks, complete information of formulary and patient historical data. Globally, the E-Prescribing market is witnessing significant growth led by various government programs to implement E-Prescribing systems in order to improve quality of healthcare and reduce medication errors. Moreover, advanced features of E-Prescribing are also supporting in growth of E-Prescribing market. Additionally, improved healthcare infrastructure has increased the demand for E-Prescribing system. Moreover, implementation of electronic healthcare records with E-Prescribing system holds immense potential for growth of E-Prescribing market. The global E-Prescribing market was valued at USD 250.2 million in 2013 and is likely to grow at a CAGR of 23.5% from 2013 to 2019 to reach USD 887.8 million by 2019.

Europe holds largest market share in the global E-Prescribing market. Integrated system is the largest E-Prescribing system and web-based E-Prescribing system is the largest delivery mode. Software is the largest component of the E-Prescribing system. Moreover, hand-held device usage mode has the largest market share and hospital is the largest end user of E-Prescribing system.

In terms of growth, North America is the fastest growing region for E-Prescribing market. Services are the fastest growing component of the E-Prescribing system. Cloud-based E-Prescribing system is the fastest growing delivery mode and office-based physician represents the fastest end-user of E-Prescribing system.

Request Sample Report at http://www.persistencemarketresearch.com/samples/3087

The global E-Prescribing market valued at USD 111.2 million in revenue in 2009. The market was expanded to USD 203.4 million in 2012, growing at a CAGR of 22.3% from 2009 to 2012.

Visit our blog at http://pmrblog.com/

About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.

Media Relations Contact

Glen Hare
Marketing Head
Persistence Market Research
646-568-7751
http://www.persistencemarketresearch.com/market-research/e-prescribing-market.asp

View this press release online at: http://rwire.com/593285